The WT1 Wilms' tumor suppressor gene: A novel target for insulin-like growth factor-I action

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4276-4279

  Bentov, Itay ^a   Leroith, Derek ^b   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN; UO 126;

ARTICLE; CELL CYCLE; CELL LINE; DOWNSTREAM PROCESSING; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0141562167     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0400     Document Type: Article

References (30)

1. Werner H, Adamo M, Roberts Jr CT, LeRoith D 1994 Molecular and cellular aspects of insulin-like growth factor action. In: Litwack G, ed. Vitamins and hormones. Vol 48. San Diego: Academic Press; 1-58
2. Daughaday W, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
3. Werner H 1999 Molecular biology of the type 1 IGF receptor. In: Rosenfeld RG, Roberts Jr CT, eds. The IGF system: molecular biology, physiology and clinical applications. Totowa, NJ: Humana Press; 63-88
4. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
5. Baserga R, Rubin R 1993 Cell cycle and growth control. Crit Rev Eukar Gene Exp 3:47-61
6. Furlanetto RW, Harwell SE, Frick KK 1994 Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol 8:510-517
7. Heidenreich KA, Zeppelin T, Robinson LJ 1993 Insulin and insulin-like growth factor I induce c-fos expression in postmitotic neurons by a protein kinase C-dependent pathway. J Biol Chem 268:14663-14670
8. Dupont J, Fernandez AM, Glackin CA, Helman L, LeRoith D 2001 Insulin-like growth factor I (IGF-I)-induced twist expression is involved in the anti-apoptotic effects of the IGF-I receptor. J Biol Chem 276:26699-26707
9. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE 1990 Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520
10. Gessler M, Poustka A, Cavence W, Neve RL, Orkin SH, Bruns GAP 1990 Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778
11. Rauscher III FJ 1993 The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7:896-903
12. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher III FJ 1991 Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6:2339-2348
13. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher III FJ, Sens DA, Garvin AJ, LeRoith D, Roberts Jr CT 1993 Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA 90:5828-5832
14. Werner H, Shen-Orr Z, Rauscher III FJ, Morris JF, Roberts Jr CT, LeRoith D 1995 Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol 15:3516-3522
15. Karnieli E, Werner H, Rauscher III FJ, Benjamin EE, LeRoith D 1996 The IGF-I receptor gene promoter is a molecular target for the Ewings' sarcoma-Wilms' tumor 1 fusion protein. J Biol Chem 271:19304-19309
16. Dong G, Rajah R, Vu T, Hoffman A, Rosenfeld R, Roberts Jr CT, Peehl DM, Cohen P 1997 Decreased expression of the Wilms' tumor gene WT-1 and elevated expression of the IGF-II and the IGF-II and IGF-IR genes in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 83:2198-2203
17. Silberstein GB, Van Horn K, Strickland P, Roberts Jr CT, Daniel CW 1997 Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94:8132-8137
18. Murata Y, Kudoh T, Sugiyama H, Toyoshima K, Akiyama T 1997 The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett 409:41-45
19. Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA 1997 Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57:1429-1434
20. Mayo MW, Wang C-Y, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS 1999 WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 18:3990-4003
21. Cohen HT, Bossone SA, Zhu G, McDonald GA, Sukhatme VP 1997 Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 272:2901-2913
22. Dehbi M, Hiscott J, Pelletier J 1998 Activation of the wt1 Wilms' tumor suppressor gene by NF-κB. Oncogene 16:2033-2039
23. McConnell MJ, Cunliffe HE, Chua LJ, Ward TA, Eccles MR 1997 Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene 14:2689-2700
24. Fraizer GC, Shimamura R, Zhang X, Saunders GF 1997 PAX8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem 272:30678-30687
25. Rupprecht HD, Drummond IA, Madden SL, Rauscher III FJ, Sukhatme VP 1994 The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206
26. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR 1996 Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 15:5606-5615
27. Idelman G, Glaser T, Roberts Jr CT, Werner H 2003 WT1-p53 interactions in IGF-I receptor gene regulation. J Biol Chem 278:3474-3482
28. Werner H, Bach MA, Stannard B, Roberts Jr CT, LeRoith D 1992 Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 6:1545-1558
29. Campbell CE, Huang A, Gurney AL, Kessler PM, Hewitt JA, Williams BRG 1994 Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus. Oncogene 9:583-595
30. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher III FJ 1991 Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 253:1550-1553